Saturday
October 24, 2026
EXHIBITS & BREAKFAST
LOBBY / PLAZA LEVEL 3
7:00 AM
7:15 AM
INDUSTRY PRODUCT THEATER
SEAPORT BALLROOM / MEZZANINE LEVEL 2
Details Coming Soon…
Heart Failure in Obstructive HCM
TREES and EXPLORERS: Myosin Inhibitor Treatment for Obstructive HCM
Iacopo Olivotto, MD
8:30 AM
Do CMIs Provide Clinical Benefit Independent of Gradient Reduction?
Evidence for Disease Modification
Sara Saberi, MD
8:50 AM
Non- or Suboptimal Responder to CMI: Definition, Who, Why, and How Best to Manage?
Harry Rakowski, MD
9:10 AM
Clouds on the Horizon: Outlook for the Future of Myosin-Modulating Therapy in HCM
Ahmad Masri, MD
9:30 AM
After 45 Years, Is There Still a Role for Disopyramide in Obstructive HCM?
Mark Sherrid, MD
9:50 AM
10:00 AM
BREAK
DEBATE: Details Coming Soon
Pro: Martin Maron, MD
Con: TBD
10:15 AM
PANEL DISCUSSION:
Translating Novel Drug Therapy Strategies to Enhance Management
Moderator: Steve Ommen, MD
Panelists: Drs. Olivotto, Saberi, Rakowski, Masri, Sherrid, M. Maron & Martinez
10:39 AM
Invasive Therapy Options
Septal Myectomy for Obstructive HCM: The Case for Surgery
Joseph Dearani, MD
11:15 AM
Obstructive with Mild Hypertrophy:
A Growing Subset Amenable to Surgical Myectomy
Prem Shekar, MD
11:40 AM
Transapical Beating Heart Myectomy: A New Era for the Surgical Treatment of HCM?
Eduard Quintana, MD
11:55 AM
12:15 PM
LUNCH/BREAK
12:20 PM
INDUSTRY PRODUCT THEATER
SEAPORT BALLROOM / MEZZANINE LEVEL 2
Details Coming Soon…
The Present and Future of Catheter-Based Therapy for HCM
Jaffar Khan, MD
1:25 PM
The Challenge of Co-Existing AS and Obstructive HCM
Jeffrey Geske, MD
1:45 PM
Contemporary Management of Obstructive HCM:
Defining the Role of SRT in an Era of Novel Drug Therapy
Steve Ommen, MD
2:00 PM
PANEL DISCUSSION: Surgery, Catheters, and CMIs—Oh My!
Moderator: Martin Maron, MD
Panelists: Drs. Dearani, Shekar, Quintana, Khan, Geske & Ommen
2:20 PM
2:50 PM
BREAK
Heart Failure in Non-Obstructive HCM
Nonobstructive HCM: Why Patients Develop Limiting Symptoms
Andrew Wang, MD
3:05 PM
The Long Odyssey of Cardiac Myosin Inhibitors for Nonobstructive HCM:
Seeing the Forest Through the Trees
Anjali Owens, MD
3:20 PM
Targeting Outside the Myosin: Future Therapies
SONATA-HCM Sharlene Day, MD, PhD
FORTITUDE-HCM Martin Maron, MD
3:45 PM
Do the Four Pillars of Conventional Heart Failure Drug Therapy Apply to End-Stage HCM? Who Should Be Listed for Heart Transplant—and When?
Michele Kittleson, MD
4:05 PM
PANEL DISCUSSION: Management of Nonobstructive HCM
Moderator: Steve Ommen, MD
Panelists: Drs. Wang, Owens, Day, M. Maron & Kittleson
4:25 PM
A Focus on Atrial Fibrillation
Predicting and Managing AF, Including the Potential for Novel Drug Therapy
Ethan Rowin, MD
4:50 PM
PFA in HCM: The New Gold Standard for AF Treatment?
Konstantyn Siontis, MD
5:05 PM
GROUP Q&A
Moderator: Martin Maron, MD
Panelists: Drs. Rowin & Siontis
5:17 PM
5:27 PM
ADJOURN
5:45 PM
INDUSTRY PRODUCT THEATER
SEAPORT BALLROOM / MEZZANINE LEVEL 2
Details Coming Soon…
HCMA RECEPTION
LIGHTHOUSE BALLROOM / MEZZANINE LEVEL 2
HOSTED BY: Lisa Salberg
SPONSOR: The Hypertrophic Cardiomyopathy Association
IN-PERSON ONLY. Program Details & RSVP Instructions Coming Soon.
7:00 PM